Achieve Life Sciences Competitors and Similar CompaniesClear all
Achieve Life Sciences's competitors and similar companies include Iterion Therapeutics, Memgen, United Therapeutics and Ayala Pharmaceuticals.
 Achieve Life Sciences Achieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients. |  Iterion Therapeutics Iterion Therapeutics is a clinical-stage biotechnology company developing targeted cancer therapeutics. |  United Therapeutics United Therapeutics is a biotechnology company that develops and manufactures pharmaceutical products for pulmonary arterial hypertension and certain cancers. |  Ayala Pharmaceuticals Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined. | ||
Founding Date | Founding Date 1995 | Founding Date 2014 | Founding Date 2004 | Founding Date 1996 | Founding Date 2017 |
Type | Type Public | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Seattle, US HQ Vancouver, CA Bothell, US Bothell, US | Locations Houston, US HQ | Locations Houston, US HQ | Locations Silver Spring, US HQ Durham, US Jacksonville, US Manchester, US Melbourne, US Washington, US | Locations Wilmington, US HQ Rehovot, IL Wilmington, US |
Employees | Employees 148% increase | Employees 17 | Employees 7 | Employees 1,16819% increase | Employees 29 |
Valuation ($) | Valuation ($) 166.2 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 15.7 b | Valuation ($) 7.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) $692k (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $384.4m (FY, 2025) | Cost of goods $602k (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $2.8b (FY, 2025) | Gross profit $90k (FY, 2022) |
Net income | Net income ($54.6m) (FY, 2025) | Net income N/A | Net income N/A | Net income $1.3b (FY, 2025) | Net income ($38m) (FY, 2022) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 2.6m (almost 8 years ago) | Latest funding round $ 865k (over 6 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 10m | Total funding raised $ 4.4m | Total funding raised $ 8.5m | Total funding raised N/A | Total funding raised $ 47m |
For sources of this data, please see the company profile
View Company Profiles
Iterion Therapeutics
HQ
Houston, US
Employees
17
Iterion Therapeutics is a clinical-stage biotechnology company developing targeted cancer therapeutics.
View companyUnited Therapeutics
HQ
Silver Spring, US
Employees
1,168↑ 19% increase
United Therapeutics is a biotechnology company that develops and manufactures pharmaceutical products for pulmonary arterial hypertension and certain cancers.
View companyAyala Pharmaceuticals
HQ
Wilmington, US
Employees
29
Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined.
View company